肝细胞生长因子模拟物ANG-3777在肾移植受者延迟移植物功能中的3期试验设计
GIFT试验为多中心双盲随机对照3期试验,评估ANG-3777(2 mg/kg静脉注射,连续3天)在肾移植后出现延迟移植物功能(DGF)患者中的疗效与安全性,主要终点为12个月时eGFR。
要点
- ANG-3777为肝细胞生长因子模拟物,2期数据提示可能改善长期肾功能。
- 主要终点为12个月eGFR,次要终点包括eGFR>30比例、住院时长和透析时长。
- 给药方案:移植后30小时内开始,2 mg/kg静脉注射,每日一次,连续3天。
核心结论
- GIFT试验将生成对改善DGF治疗重要的数据,该人群医疗复杂。
研究设计与样本
- 多中心、双盲、随机对照3期试验,受试者按1:1随机分配至ANG-3777(2 mg/kg)组或安慰剂组。
关键数值与推荐
- 主要终点为12个月时估算肾小球滤过率(eGFR)。
- 次要终点包括第30、90、180、360天eGFR>30的受试者比例、移植物功能缓慢/延迟/原发性无功能的比例、住院时长及至第30天的透析持续时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: One-third of kidney transplantation patients experience acute kidney injury (AKI) resulting in delayed graft function (DGF), associated with increased risk of graft failure and mortality. Preclinical and phase 2 data indicate that treatment with ANG-3777 (formerly BB3), a hepatocyte growth factor (HGF) mimetic, may improve long-term kidney function and reduce health care resource use and cost, but these data require validation in a phase 3 randomized controlled trial. METHODS: The Graft Improvement Following Transplant (GIFT) trial is a multicenter, double-blind randomized controlled trial, designed to determine the efficacy and safety of ANG-3777 in renal transplantation patients showing signs of DGF. Subjects are randomized 1:1 to ANG-3777 (2 mg/kg) administered intravenously once daily for 3 consecutive days starting within 30 hours after transplantation, or to placebo. RESULTS: The primary endpoint is estimated glomerular filtration rate (eGFR) at 12 months. Secondary endpoints include proportion of subjects with eGFR >30 at days 30, 90, 180, and 360; proportion of subjects whose graft function is slow, delayed, or primary nonfunction; length of hospitalization; and duration of dialysis through day 30. Adverse events are assessed throughout the study. CONCLUSION: GIFT will generate data that are important to advancing treatment of DGF in this medically complex population.
引用
- Vincenti F, Kim J, Gouveia D, et al. Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function. Kidney Int Rep. 2020. PMID: 33615054. doi:10.1016/j.ekir.2020.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。